RE: AGM20 Jun 2024 21:28
@nemethv
Thank you for your thoughtful response.
I wouldn't go so far as to call you selfish negatively.
We both wish the share price to go up and make a profit.
I would have given all I had invested in Hemogenyx to Cancer Research UK if I hadn't.
I just don't see the need for a blame game, and I don't think we would be a 100 million company by now if we had a CEO with a doctorate in economics at the helm.
What would a CEO with a doctorate in economics have done differently?
Selling one of our assets cheaply is not my cup of tea.
Nor is a CEO who is talking up the share and it turns out to be hot air and not much more.
The market is tough at the moment, so I think the BOD has done well in raising cash.
They will need more cash, and if they do not manage to get it in a non-dilutive way, there is no other option than going to the market again.
At that time, I hope the share price has risen due to the start of clinical trials.
But there is no guarantee that that will happen.
I also thought the share price would rise when we became clinical.
Look where we are now. (down, if anyone is in doubt:-)
That is just the market at the moment. Especially if you're not in the hot air selling business.
(and I am glad that we aren't)
The price will rise when the market catches on. When will that be, and what will be the trigger event?
A good question, that is blowing in the wind.